Abstract
Objectives: To characterize the psoriasis-associated inflammatory transcriptome in lesional and nonlesional subdermal adipose tissue from patients with psoriasis, and to determine whether secukinumab, an interleukin (IL)-17A inhibitor, modulates these inflammatory gene transcripts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have